experspadmin

Immune Dysfunction and Infection Risk in Chronic Lymphocytic Leukemia
Oncology

Immune Dysfunction and Infection Risk in Chronic Lymphocytic Leukemia

expert roundtables
By Anthony R. Mato, MD, MSCE; Jan A. Burger, MD, PhD; Jennifer R. Brown, MD, PhD
Identifying the Role of Disease-Modifying Drugs in the Treatment of Patients With Multiple Sclerosis
Neurology

Identifying the Role of Disease-Modifying Drugs in the Treatment of Patients With Multiple Sclerosis

expert roundtables
By David A. Hafler, MD; Dean Wingerchuk, MD, FRCP(C), MSc; Staley Brod, MD
Unmet Need of Cognitive Decline in Patients With Multiple Sclerosis
Neurology

Unmet Need of Cognitive Decline in Patients With Multiple Sclerosis

clinical topic updates
By Dean Wingerchuk, MD, FRCP(C), MSc
Neurology

Reducing Relapse Rates and Disease Progression With Disease-Modifying Therapies in Patients With Multiple Sclerosis

clinical topic updates
By Dean Wingerchuk, MD, FRCP(C), MSc
Treatment Goals and Strategies for Patients With Primary Progressive Multiple Sclerosis
Neurology

Treatment Goals and Strategies for Patients With Primary Progressive Multiple Sclerosis

expert roundtables
By Aaron Miller, MD; Patricia K. Coyle, MD, FAAN, FANA; Scott Newsome, DO, MSCS, FAAN
Load More